Recruiting
Acquired antithrombin III deficiency+1
RecruitingStudy on Antithrombin III Human for Patients with Heparin Resistance Undergoing Cardiac Surgery with Cardiopulmonary Bypass
Registered drug
Study on Antithrombin III Human for Patients with Heparin Resistance Undergoing Cardiac Surgery with Cardiopulmonary Bypass
Registered drug
- Disease:Acquired antithrombin III deficiencyHeparin resistance
- Substances:Antithrombin Iii Human
Countries:
Austria
Austria- Participants:18–64 years · 65+ years
- Substances:Antithrombin Iii Human
- Sponsor:Octapharma AG



